Show of Hands

FDA slows down progress: demands more data/tests/procedures on more subjects B4 approving a drug. Clinical trials R longer/larger/more complex. Result: cost of developing new drugs skyrockets & the time it takes to get drugs to the dying is slowing.

Bad FDA Good FDA

1 Liked